About Collagen alpha-1(XXIII) chain
Collagen alpha-1(XXIII) chain (COL23A1) is a protein
from Homo sapiens identified by UniProt accession
Q86Y22, 540 residues long.
MolForge cross-references it against 0 known binders and
48 disease associations.
Target properties
| Protein name | Collagen alpha-1(XXIII) chain |
| UniProt accession | Q86Y22 |
| Gene | COL23A1 |
| Organism | Homo sapiens |
| Length | 540 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (48)
Diseases linked to this target (Open Targets).
- prostate carcinoma · score 0.40
- nose morphology measurement · score 0.33
- balding measurement · score 0.28
- breast adenocarcinoma · score 0.26
- lung adenocarcinoma · score 0.18
- insomnia · score 0.18
- total blood protein measurement · score 0.18
- gut microbiome measurement · score 0.15
- DNA methylation · score 0.14
- endometrial cancer · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86Y22-F1 | alphafold | PREDICTED | 58.90 | — |
Amino-acid sequence (540 residues)
MGPGERAGGG GDAGKGNAAG GGGGGRSATT AGSRAVSALC LLLSVGSAAA CLLLGVQAAA LQGRVAALEE ERELLRRAGP PGALDAWAEP HLERLLREKL DGLAKIRTAR EAPSECVCPP GPPGRRGKPG RRGDPGPPGQ SGRDGYPGPL GLDGKPGLPG PKGEKGAPGD FGPRGDQGQD GAAGPPGPPG PPGARGPPGD TGKDGPRGAQ GPAGPKGEPG QDGEMGPKGP PGPKGEPGVP GKKGDDGTPS QPGPPGPKGE PGSMGPRGEN GVDGAPGPKG EPGHRGTDGA AGPRGAPGLK GEQGDTVVID YDGRILDALK GPPGPQGPPG PPGIPGAKGE LGLPGAPGID GEKGPKGQKG DPGEPGPAGL KGEAGEMGLS GLPGADGLKG EKGESASDSL QESLAQLIVE PGPPGPPGPP GPMGLQGIQG PKGLDGAKGE KGASGERGPS GLPGPVGPPG LIGLPGTKGE KGRPGEPGLD GFPGPRGEKG DRSERGEKGE RGVPGRKGVK GQKGEPGPPG LDQPCPVGPD GLPVPGCWHK
Explore Collagen alpha-1(XXIII) chain with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets